Tutorial outlining the manual implementation of the DrugGenEx-NET methodology. (DOCX 14Â kb
We have chosen 21 features from network-based measures and other functional data: (i) General featur...
The disease-gene associations. This file contains the researched diseases and their associated genes...
1246 (1201 unique drugbankID) candidate drugs for drug repositioning that targeted to PD modules. (X...
Validations of predicted drug-disease associations from the literature. (XLS 38Â kb
Top 50 predicted drugs and validations for Alzheimer’s Disease and Parkinson’s Disease. (XLS 39 kb
Predicted drug-target-disease associations using OMIM. For each human protein target crystal structu...
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disru...
(1) Constructing a drug-specific pathway. Figure S5. Schematic illustration of component-specific pa...
Analysis of variance of 14 bioequivalence studies on 14 immediate-release, non-combinational, oral d...
Collection of drug modules in GMT format. The first column indicates the name of the drug while the ...
Table S3. Drug repositioning hypotheses based on the significance of the overlap between genes genet...
Enriched (p value < 0.001) drug module count across 31 TCGA cancer types, i.e., number of patients w...
Genes and variants not considered in current drug response predictions. (XLSX 36 kb
Table S1. Summary of basic information of different methods in GeNeCK. (DOCX 14 kb
Supplementary methods. Describing the generation process of compound descriptors and protein descrip...
We have chosen 21 features from network-based measures and other functional data: (i) General featur...
The disease-gene associations. This file contains the researched diseases and their associated genes...
1246 (1201 unique drugbankID) candidate drugs for drug repositioning that targeted to PD modules. (X...
Validations of predicted drug-disease associations from the literature. (XLS 38Â kb
Top 50 predicted drugs and validations for Alzheimer’s Disease and Parkinson’s Disease. (XLS 39 kb
Predicted drug-target-disease associations using OMIM. For each human protein target crystal structu...
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disru...
(1) Constructing a drug-specific pathway. Figure S5. Schematic illustration of component-specific pa...
Analysis of variance of 14 bioequivalence studies on 14 immediate-release, non-combinational, oral d...
Collection of drug modules in GMT format. The first column indicates the name of the drug while the ...
Table S3. Drug repositioning hypotheses based on the significance of the overlap between genes genet...
Enriched (p value < 0.001) drug module count across 31 TCGA cancer types, i.e., number of patients w...
Genes and variants not considered in current drug response predictions. (XLSX 36 kb
Table S1. Summary of basic information of different methods in GeNeCK. (DOCX 14 kb
Supplementary methods. Describing the generation process of compound descriptors and protein descrip...
We have chosen 21 features from network-based measures and other functional data: (i) General featur...
The disease-gene associations. This file contains the researched diseases and their associated genes...
1246 (1201 unique drugbankID) candidate drugs for drug repositioning that targeted to PD modules. (X...
DOI
Add to ORKG